Mirador is a next-generation precision medicine company focused on immunology and inflammation. The company’s Mirador360 TM precision development engine leverages the latest advances in human genetics and cutting-edge data science to rapidly advance new precision medicines for patients living with chronic immune-mediated inflammatory and fibrotic diseases. Launched in 2024, Mirador has raised over $400 million from leading life sciences investors and is based in San Diego, CA. 

Life Sciences

Mirador Therapeutics

Mark McKenna

Tim Andrews

Olivier Laurent

Maulik S.

Vika Brough

Nori Ebersole

Jordan Zwick

Allison Luo

The Leadership Team at Mirador Therapeutics is responsible for setting the strategic direction and vision of the company, ensuring alignment with its mission to advance precision medicines for immune-mediated inflammatory and fibrotic diseases. This team oversees critical functions including scientific research, legal affairs, financial management, executive leadership, medical strategy, human resources, business development, and strategic planning to drive the company's growth and success.

Leadership Team

Research and Development

Leadership Team

About

Team members

Other teams at Mirador Therapeutics

Research and Development